Biogen and GlaxoSmithKline-backed CalciMedica has received series C capital to advance a possible Covid-19 treatment through clinical testing.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

UBS O’Connor contributed to a round that pushed the total raised by the socially responsible digital bank past the $200m mark.

Assurant, Scor Global P&C Ventures and Lennar Ventures all contributed to the series C round for States Title, a developer of technology that streamlines real estate deals.

M12 and Samsung Next helped add $11m to a first tranche that closed in January, taking the customer service software developer's overall funding to more than $63m.

Smart customer service technology provider Sobot received $29.5m in a round co-led by Yonyou, with the cash earmarked for product development and marketing.

Takeda and existing investor Allianz X took part in a series C round closed in the wake of heightened demand for Amwell's telehealth technology platform.

Pfizer, Lundbeckfonden Ventures and Biomed Ventures have all taken part in a round for the anti-infective therapy developer that has now passed $90m.

The customer service technology developer has raised $21.1m from investors including Beijing Kunlun Technology in a round co-led by Blue Lake Capital and Eastern Bell Venture Capital.

Existing investors Cavallo Ventures and Syngenta Ventures returned to reinvest in the crop production technology developer’s series C round.